| Federated learning enables big data for rare cancer boundary detection S Pati, U Baid, B Edwards, M Sheller, SH Wang, GA Reina, P Foley, ... Nature communications 13 (1), 7346, 2022 | 213 | 2022 |
| Diffusion MRI phenotypes predict overall survival benefit from anti-VEGF monotherapy in recurrent glioblastoma: converging evidence from phase II trials BM Ellingson, ER Gerstner, M Smits, RY Huang, R Colen, LE Abrey, ... Clinical Cancer Research 23 (19), 5745-5756, 2017 | 74 | 2017 |
| Simultaneous p H‐sensitive and oxygen‐sensitive MRI of human gliomas at 3 T using multi‐echo amine proton chemical exchange saturation transfer spin‐and‐gradient echo echo … RJ Harris, J Yao, A Chakhoyan, C Raymond, K Leu, LM Liau, ... Magnetic resonance in medicine 80 (5), 1962-1978, 2018 | 55 | 2018 |
| Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH-and oxygen-sensitive molecular MRI J Yao, A Chakhoyan, DA Nathanson, WH Yong, N Salamon, C Raymond, ... Neuro-oncology 21 (9), 1184-1196, 2019 | 53 | 2019 |
| Synthesizing MR image contrast enhancement using 3D high-resolution ConvNets C Chen, C Raymond, W Speier, X Jin, TF Cloughesy, D Enzmann, ... IEEE Transactions on Biomedical Engineering 70 (2), 401-412, 2022 | 47 | 2022 |
| 18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study CB Patel, E Fazzari, A Chakhoyan, J Yao, C Raymond, H Nguyen, ... Journal of neuro-oncology 139, 399-409, 2018 | 47 | 2018 |
| Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study J Yao, A Hagiwara, C Raymond, S Shabani, WB Pope, N Salamon, A Lai, ... Scientific reports 10 (1), 11922, 2020 | 46 | 2020 |
| pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma J Yao, CHP Tan, J Schlossman, A Chakhoyan, C Raymond, WB Pope, ... Journal of neuro-oncology 142, 587-595, 2019 | 41 | 2019 |
| Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma BM Ellingson, DT Aftab, GM Schwab, C Hessel, RJ Harris, DC Woodworth, ... Neuro-oncology 20 (10), 1411-1418, 2018 | 36 | 2018 |
| pH-weighted molecular MRI in human traumatic brain injury (TBI) using amine proton chemical exchange saturation transfer echoplanar imaging (CEST EPI) BM Ellingson, J Yao, C Raymond, A Chakhoyan, K Khatibi, N Salamon, ... NeuroImage: Clinical 22, 101736, 2019 | 30 | 2019 |
| Association between tumor acidity and hypervascularity in human gliomas using pH-weighted amine chemical exchange saturation transfer echo-planar imaging and dynamic … YL Wang, J Yao, A Chakhoyan, C Raymond, N Salamon, LM Liau, ... American Journal of Neuroradiology 40 (6), 979-986, 2019 | 29 | 2019 |
| Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET H Tatekawa, A Hagiwara, H Uetani, S Bahri, C Raymond, A Lai, ... Cancer Imaging 21, 1-10, 2021 | 20 | 2021 |
| Improving B0 correction for pH-weighted amine proton chemical exchange saturation transfer (CEST) imaging by use of K-means clustering and Lorentzian estimation J Yao, D Ruan, C Raymond, LM Liau, N Salamon, WB Pope, ... Tomography 4 (3), 123-137, 2018 | 20 | 2018 |
| Diffusion magnetic resonance imaging phenotypes predict overall survival benefit from bevacizumab or surgery in recurrent glioblastoma with large tumor burden KS Patel, RG Everson, J Yao, C Raymond, J Goldman, J Schlossman, ... Neurosurgery 87 (5), 931-938, 2020 | 19 | 2020 |
| Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo BM Ellingson, LE Abrey, J Garcia, O Chinot, W Wick, F Saran, ... Neuro-oncology 20 (11), 1525-1535, 2018 | 19 | 2018 |
| Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors A Hagiwara, TC Oughourlian, NS Cho, J Schlossman, C Wang, J Yao, ... Neuro-oncology 24 (6), 1020-1028, 2022 | 18 | 2022 |
| Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging H Akbari, AF Kazerooni, JB Ware, E Mamourian, H Anderson, S Guiry, ... Scientific reports 11 (1), 15011, 2021 | 18 | 2021 |
| Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma KS Patel, J Yao, C Raymond, W Yong, R Everson, LM Liau, D Nathanson, ... Scientific reports 10 (1), 14819, 2020 | 16 | 2020 |
| Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas TC Oughourlian, J Yao, J Schlossman, C Raymond, M Ji, H Tatekawa, ... Journal of neuro-oncology 147, 135-145, 2020 | 16 | 2020 |
| Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients WJ Chwa, TA Tishler, C Raymond, C Tran, F Anwar, JP Villablanca, ... Schizophrenia research 222, 397-410, 2020 | 15 | 2020 |
Benjamin EllingsonUniversity of California Los Angeles在 mednet.ucla.edu 的电子邮件经过验证
